These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24042193)

  • 1. Integrin alpha 6: a novel therapeutic target in esophageal squamous cell carcinoma.
    Kwon J; Lee TS; Lee HW; Kang MC; Yoon HJ; Kim JH; Park JH
    Int J Oncol; 2013 Nov; 43(5):1523-30. PubMed ID: 24042193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenic role of podoplanin in esophageal squamous-cell carcinoma.
    Rahadiani N; Ikeda J; Makino T; Tian T; Qiu Y; Mamat S; Wang Y; Doki Y; Aozasa K; Morii E
    Ann Surg Oncol; 2010 May; 17(5):1311-23. PubMed ID: 20066519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional factor Prox1 plays an essential role in the antiproliferative action of interferon-γ in esophageal cancer cells.
    Akagami M; Kawada K; Kubo H; Kawada M; Takahashi M; Kaganoi J; Kato S; Itami A; Shimada Y; Watanabe G; Sakai Y
    Ann Surg Oncol; 2011 Dec; 18(13):3868-77. PubMed ID: 21452064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 expression is enhanced by Twist1 and associated with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro and in vivo.
    Lee KW; Sung CO; Kim JH; Kang M; Yoo HY; Kim HH; Um SH; Kim SH
    Int J Cancer; 2015 Jan; 136(2):310-21. PubMed ID: 24895167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. XB130 as an independent prognostic factor in human esophageal squamous cell carcinoma.
    Shiozaki A; Kosuga T; Ichikawa D; Komatsu S; Fujiwara H; Okamoto K; Iitaka D; Nakashima S; Shimizu H; Ishimoto T; Kitagawa M; Nakou Y; Kishimoto M; Liu M; Otsuji E
    Ann Surg Oncol; 2013 Sep; 20(9):3140-50. PubMed ID: 22805860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
    Tang KH; Dai YD; Tong M; Chan YP; Kwan PS; Fu L; Qin YR; Tsao SW; Lung HL; Lung ML; Tong DK; Law S; Chan KW; Ma S; Guan XY
    Cancer Res; 2013 Apr; 73(7):2322-32. PubMed ID: 23382045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stomatin-like protein 2 is overexpressed in cancer and involved in regulating cell growth and cell adhesion in human esophageal squamous cell carcinoma.
    Zhang L; Ding F; Cao W; Liu Z; Liu W; Yu Z; Wu Y; Li W; Li Y; Liu Z
    Clin Cancer Res; 2006 Mar; 12(5):1639-46. PubMed ID: 16533792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of sex-determining region Y-box 9 (SOX9) promotes cell proliferation and tumorigenicity in esophageal squamous cell carcinoma.
    Hong Y; Chen W; Du X; Ning H; Chen H; Shi R; Lin S; Xu R; Zhu J; Wu S; Zhou H
    Oncotarget; 2015 Oct; 6(31):31241-54. PubMed ID: 26384302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of tumor necrosis factor receptor-associated protein 1 expression induces inhibition of cell proliferation and tumor growth in human esophageal cancer cells.
    Tian X; Ma P; Sui CG; Meng FD; Li Y; Fu LY; Jiang T; Wang Y; Jiang YH
    FEBS J; 2014 Jun; 281(12):2805-19. PubMed ID: 24754231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of differentially expressed cancer-related genes in esophageal squamous cell carcinoma (ESCC) using human cancer cDNA arrays: overexpression of oncogene MET correlates with tumor differentiation in ESCC.
    Hu YC; Lam KY; Law S; Wong J; Srivastava G
    Clin Cancer Res; 2001 Nov; 7(11):3519-25. PubMed ID: 11705871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
    Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
    Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EpCAM, a potential therapeutic target for esophageal squamous cell carcinoma.
    Matsuda T; Takeuchi H; Matsuda S; Hiraiwa K; Miyasho T; Okamoto M; Kawasako K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S356-64. PubMed ID: 24566863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma.
    Gong H; Song L; Lin C; Liu A; Lin X; Wu J; Li M; Li J
    Clin Cancer Res; 2013 Mar; 19(5):1083-93. PubMed ID: 23319823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer.
    Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H
    Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP is a candidate oncogene for esophageal squamous cell carcinoma.
    Muramatsu T; Imoto I; Matsui T; Kozaki K; Haruki S; Sudol M; Shimada Y; Tsuda H; Kawano T; Inazawa J
    Carcinogenesis; 2011 Mar; 32(3):389-98. PubMed ID: 21112960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells.
    Yoshinaga K; Yamashita K; Mimori K; Tanaka F; Inoue H; Mori M
    Ann Surg Oncol; 2008 Jan; 15(1):96-103. PubMed ID: 17909904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.
    Wang X; Li M; Wang Z; Han S; Tang X; Ge Y; Zhou L; Zhou C; Yuan Q; Yang M
    J Biol Chem; 2015 Feb; 290(7):3925-35. PubMed ID: 25538231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma.
    Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y
    Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.